140 related articles for article (PubMed ID: 11689042)
1. The Epstein-Barr virus encoded latent membrane protein 2A augments signaling from latent membrane protein 1.
Dawson CW; George JH; Blake SM; Longnecker R; Young LS
Virology; 2001 Oct; 289(2):192-207. PubMed ID: 11689042
[TBL] [Abstract][Full Text] [Related]
2. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
Swart R; Fruehling S; Longnecker R
Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
[TBL] [Abstract][Full Text] [Related]
3. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
[TBL] [Abstract][Full Text] [Related]
4. The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.
Ikeda M; Ikeda A; Longan LC; Longnecker R
Virology; 2000 Mar; 268(1):178-91. PubMed ID: 10683340
[TBL] [Abstract][Full Text] [Related]
5. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells.
Yang J; Deng X; Deng L; Gu H; Fan W; Cao Y
J Exp Clin Cancer Res; 2004 Sep; 23(3):495-506. PubMed ID: 15595642
[TBL] [Abstract][Full Text] [Related]
6. The latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus induces expression of the putative oncogene Bcl-3 through activation of the nuclear factor-kappaB.
Nakamura H; Ishii C; Suehiro M; Iguchi A; Kuroda K; Shimizu K; Shimizu N; Imadome K; Yajima M; Fujiwara S
Virus Res; 2008 Feb; 131(2):170-9. PubMed ID: 17963943
[TBL] [Abstract][Full Text] [Related]
7. The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.
Blake SM; Eliopoulos AG; Dawson CW; Young LS
Virology; 2001 Apr; 282(2):278-87. PubMed ID: 11289810
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.
Li HM; Zhuang ZH; Wang Q; Pang JC; Wang XH; Wong HL; Feng HC; Jin DY; Ling MT; Wong YC; Eliopoulos AG; Young LS; Huang DP; Tsao SW
Oncogene; 2004 May; 23(25):4488-94. PubMed ID: 15064751
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.
Stewart S; Dawson CW; Takada K; Curnow J; Moody CA; Sixbey JW; Young LS
Proc Natl Acad Sci U S A; 2004 Nov; 101(44):15730-5. PubMed ID: 15498875
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus latent membrane protein 1 induces micronucleus formation, represses DNA repair and enhances sensitivity to DNA-damaging agents in human epithelial cells.
Liu MT; Chen YR; Chen SC; Hu CY; Lin CS; Chang YT; Wang WB; Chen JY
Oncogene; 2004 Apr; 23(14):2531-9. PubMed ID: 14716302
[TBL] [Abstract][Full Text] [Related]
11. Epstein-barr virus latent membrane protein 1 induces and causes release of fibroblast growth factor-2.
Wakisaka N; Murono S; Yoshizaki T; Furukawa M; Pagano JS
Cancer Res; 2002 Nov; 62(21):6337-44. PubMed ID: 12414666
[TBL] [Abstract][Full Text] [Related]
12. Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.
Zheng H; Li LL; Hu DS; Deng XY; Cao Y
Cell Mol Immunol; 2007 Jun; 4(3):185-96. PubMed ID: 17601372
[TBL] [Abstract][Full Text] [Related]
13. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1.
Song X; Tao YG; Deng XY; Jin X; Tan YN; Tang M; Wu Q; Lee LM; Cao Y
Cell Signal; 2004 Oct; 16(10):1153-62. PubMed ID: 15240010
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus latent membrane protein 1 represses p53-mediated DNA repair and transcriptional activity.
Liu MT; Chang YT; Chen SC; Chuang YC; Chen YR; Lin CS; Chen JY
Oncogene; 2005 Apr; 24(16):2635-46. PubMed ID: 15829976
[TBL] [Abstract][Full Text] [Related]
15. Lack of cytotoxic property in a variant of Epstein-Barr virus latent membrane protein-1 isolated from nasopharyngeal carcinoma.
Nitta T; Chiba A; Yamamoto N; Yamaoka S
Cell Signal; 2004 Sep; 16(9):1071-81. PubMed ID: 15212767
[TBL] [Abstract][Full Text] [Related]
16. Rhesus lymphocryptovirus latent membrane protein 2A activates beta-catenin signaling and inhibits differentiation in epithelial cells.
Siler CA; Raab-Traub N
Virology; 2008 Aug; 377(2):273-9. PubMed ID: 18570966
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K.
Mainou BA; Everly DN; Raab-Traub N
Oncogene; 2005 Oct; 24(46):6917-24. PubMed ID: 16007144
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the phosphorylation status of Epstein-Barr virus LMP2A in epithelial cells.
Scholle F; Longnecker R; Raab-Traub N
Virology; 2001 Dec; 291(2):208-14. PubMed ID: 11878890
[TBL] [Abstract][Full Text] [Related]
19. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent manner.
Tao YG; Tan YN; Liu YP; Song X; Zeng L; Gu HH; Tang M; Li W; Yi W; Cao Y
Cell Signal; 2004 Jul; 16(7):781-90. PubMed ID: 15115657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]